| RS1553685707 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1553685927 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553686314 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS1553686321 |
SLC25A20
|
Health Risk |
Pathogenic |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS1553686345 |
SLC25A20
|
Health Risk |
Pathogenic |
— |
| RS1553686994 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553687058 |
IMPG2
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1553687118 |
IMPG2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 56, Retinitis pigmentosa 56 |
| RS1553687219 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553687863 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1553687887 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1553687898 |
LMOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1553687907 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553688015 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1553688242 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553688330 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1553688335 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553688405 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1553688696 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS1553688712 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553688916 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553688970 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, SLC6A1-related neurodevelopmental disorder |
| RS1553689057 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553689580 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Epilepsy with myoclonic atonic seizures |
| RS1553689664 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553689696 |
SLC6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Inborn genetic diseases |
| RS1553689752 |
ITPR1
|
Health Risk |
Pathogenic |
Gillespie syndrome, Gillespie syndrome |
| RS1553689774 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553689859 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, SLC6A1-related disorder |
| RS1553690406 |
GBE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type IV |
| RS1553690421 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS1553690452 |
SLC6A1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553690565 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Benign familial hematuria |
| RS1553690583 |
SLC6A1
|
Health Risk |
Pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1553690601 |
SLC6A1
|
Health Risk |
Pathogenic |
— |
| RS1553690604 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553690979 |
ASXL2
|
Health Risk |
Likely pathogenic |
— |
| RS1553691122 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553691187 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553691320 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1553691555 |
ASXL2
|
Health Risk |
Pathogenic |
— |
| RS1553691674 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1553691918 |
GMPPB
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS1553691975 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS1553692107 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553692140 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553692290 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553692416 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiac arrhythmia |
| RS1553692435 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553692660 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553692734 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553692822 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553693059 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553693444 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553693702 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS1553693712 |
BRPF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553693863 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS1553694247 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 3, Long QT syndrome 3 |
| RS1553694398 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome (shorter-than-normal QT interval), Brugada syndrome (shorter-than-normal QT interval) |
| RS1553694426 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553694860 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553695017 |
BRPF1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Intellectual developmental disorder with dysmorphic facies and ptosis |
| RS1553695038 |
BRPF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553695209 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553695222 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS1553695254 |
BRPF1
|
Health Risk |
Pathogenic |
— |
| RS1553695282 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Brugada syndrome |
| RS1553695389 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Diffuse mesangial sclerosis |
| RS1553695398 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553695557 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553695749 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1553695764 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Brugada syndrome (shorter-than-normal QT interval), Brugada syndrome 1 |
| RS1553695847 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553696121 |
CPOX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553696207 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1553696233 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553696275 |
BRPF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553696411 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553696482 |
IFIH1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS1553696573 |
CPOX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553696647 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553696967 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553697218 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553697341 |
BRPF1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and ptosis, Inborn genetic diseases |
| RS1553698475 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553698563 |
SCN5A
|
Health Risk |
Likely pathogenic |
Long QT syndrome 1, Cardiovascular phenotype |
| RS1553698852 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553699111 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS1553699115 |
SETD2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neoplasm |
| RS1553699226 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553699238 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553699292 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553699440 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553699454 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Dilated cardiomyopathy 1G |
| RS1553699607 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS1553699620 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1553699663 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS1553699747 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553699766 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome (shorter-than-normal QT interval), Brugada syndrome (shorter-than-normal QT interval) |
| RS1553699802 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |